Navigating Biotech Mergers and Acquisitions | Steve St. Onge, Paratek Pharmaceuticals

In this enlightening episode of The Business of Pharmacy Podcast, we delve into the intricate world of mergers and acquisitions in the biotech sector with Steve St. Onge, a seasoned expert from Paratech Pharmaceuticals. Steve shares valuable insights into the challenges and strategies of managing a single-product company in a volatile market, exploring the dynamics of both buy-side and sell-side M&As. His journey from a clinical practitioner to a corporate development leader offers a unique perspective on the biotech landscape. https://www.paratekpharma.com/ [00:00:12] - Introduction of Steve St. Onge [00:00:44] - Challenges for single-product companies [00:02:20] - Strategic reasons behind M&As [00:06:49] - Initiation of merger discussions [00:10:21] - Role of relationships in M&A [00:13:12] - Emotional aspects of biotech M&A [00:16:14] - Clinical to corporate transition [00:19:39] - Persistence in M&A success [00:27:18] - Drug development and M&A impact [00:35:19] - PharmD to MBA growth journey ⁠The Business of Pharmacy Podcast™⁠ offers in-depth, candid conversations with pharmacy business leaders. Hosted by pharmacist Mike Koelzer, each episode covers new topics relevant to pharmacists and pharmacy owners. Listen to a new episode every Monday morning.